# Selection of Resistant Mutations to Dolutegravir in PLWH Treated in Mozambique

> **NCT06607588** · — · RECRUITING · sponsor: **Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia** · enrollment: 200 (estimated)

## Conditions studied

- HIV
- HIV Antiretroviral Therapy (ART) Adherence

## Interventions

- **OTHER:** Not applicable- observational study

## Key facts

- **NCT ID:** NCT06607588
- **Lead sponsor:** Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-10-25
- **Primary completion:** 2026-04
- **Final completion:** 2026-09
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2025-05-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06607588

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06607588, "Selection of Resistant Mutations to Dolutegravir in PLWH Treated in Mozambique". Retrieved via MORVS 2026-09-29 from https://api.morvs.ai/clinical/NCT06607588. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*